Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia

Journal of Veterinary Internal Medicine

Volumn 18, Issue 4, 2004, Pages 568-573

  Giguère, Steeve ^a   Jacks, Stephanie ^a   Roberts, Gregory D ^a   Hernandez, Jorge ^a   Long, Maureen T ^a   Ellis, Christina ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

Antimicrobials; Lung; Pulmonary abscesses; Respiratory tract infection; Rifampin

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; RIFAMPICIN;

ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CORYNEBACTERIUM EQUI; DIARRHEA; DRUG EFFICACY; FEMALE; HORSE DISEASE; MALE; NONHUMAN; TREATMENT OUTCOME;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; FEMALE; FLORIDA; HORSE DISEASES; HORSES; MALE; PNEUMONIA, BACTERIAL; RECORDS; RETROSPECTIVE STUDIES; RHODOCOCCUS EQUI; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); CORYNEBACTERIUM; EQUUS CABALLUS; RHODOCOCCUS; RHODOCOCCUS EQUI;

EID: 4243178082     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<568:RCOACA>2.0.CO;2     Document Type: Article

References (23)

1. Giguère S, Prescott JF. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 1997;56:313-334.
2. Lakritz J, Wilson WD, Mihalyi JE. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. Am J Vet Res 1999;60:414-419.
3. Lakritz J, Wilson WD, Marsh AE, et al. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am J Vet Res 2000;61:914-919.
4. Stratton-Phelps M, Wilson WD, Gardner IA. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J Am Vet Med Assoc 2000;217:68-73.
5. Baverud V, Franklin A, Gunnarsson A, et al. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Vet J 1998;30:482-488.
6. Whitman MS, Tunkel AR. Azithromycin and clarithromycin: Overview and comparison with erythromycin. Infect Control Hosp Epidemiol 1992;13:357-368.
7. Anderson G, Esmonde TS, Coles S, et al. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. J Antimicrob Chemother 1991;27(Suppl A):117-124.
8. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991;91:40S-45S.
9. Davis JL, Gardner SY, Jones SL, et al. Pharmacokinetics of azithromycin in foals after I.V. and oral dose and disposition into phagocytes. J Vet Pharmacol Ther 2002;25:99-104.
10. Jacks S, Giguère S, Gronwall RR, et al. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. Am J Vet Res 2001;62:1870-1875.
11. Jacks S, Giguère S, Gronwall RR, et al. Disposition of oral clarithromycin in foals. J Vet Pharmacol Ther 2002;25:359-362.
12. Jacks S, Giguère S, Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin and 20 other antimicrobials. Antimicrob Agents Chemother 2003;47:1742-1745.
13. Elissalde GS, Renshaw HW, Walberg JA. Corynebacterium equi: An interhost review with emphasis on the foal. Comp Immunol Microbiol Infect Dis 1980;3:433-445.
14. Ainsworth DM, Bicker SW, Yeagar AE, et al. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992). J Am Vet Med Assoc 1998;213:510-515.
15. Chaffin MK, Martens RJ. Extrapulmonary disorders associated with Rhodococcus equi pneumonia in foals: Retrospective study of 61 cases (1988-1996). American Association of Equine Practioners 43rd Annual Convention, Phoenix, AZ, December 1997.
16. Hillidge CJ. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet Microbiol 1987;14:337-342.
17. Falcon J, Smith BP, O'Brien TR, et al. Clinical and radiographic findings in Corynebacterium equi pneumonia of foals. J Am Vet Med Assoc 1985;186:593-599.
18. Sweeney CR, Sweeney RW, Divers TJ. Rhodococcus equi pneumonia in 48 foals: Response to antimicrobial therapy. Vet Microbiol 1987;14:329-336.
19. Maurin M, Raoult D. Antibiotic penetration within phagocytic cells. In: Raoult D, ed. Antimicrobial Agents and Intracellular Pathogens. Boca Raton, FL: CRC Press; 1993:23-37.
20. Ward TT, Rimland D, Kauffman C, et al. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. Clin Infect Dis 1998;27:1278-1285.
21. Patel KB, Xuan D, Tessier PR, et al. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother 1996;40:2375-2379.
22. Rodvold KA, Gotfried MH, Danziger LH, et al. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother 1997;41:1399-1402.
23. Conte JE, Golden J, Duncan S, et al. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob Agents Chemother 1996;40:1617-1622.